Thioridazine: a radiation enhancer in advanced cervical cancer?
D002294:Carcinoma, Squamous Cell / Q000517:prevention & control*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010386:Pelvic Neoplasms / Q000532:radiotherapy; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D013881:Thioridazine / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D014625:Vaginal Neoplasms / Q000532:radiotherapy
D011838:Radiation-Sensitizing Agents; D013881:Thioridazine